Literature DB >> 30592644

Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome.

Laura Pala1, Luigi Nezi1, Tommaso De Pas1, Elisabetta Pennacchioli1, Emilia Cocorocchio1, Pierfrancesco Ferrucci1, Fabio Conforti1, Aron Goldhirsch1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30592644     DOI： 10.1200/JCO.18.01270

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer.

Authors:  Aparna Mitra; Greyson Willis Grossman Biegert; Andrea Y Delgado; Tatiana V Karpinets; Travis N Solley; Melissa P Mezzari; Kyoko Yoshida-Court; Joe F Petrosino; Megan D Mikkelson; Lilie Lin; Patricia Eifel; Jianhua Zhang; Lois M Ramondetta; Anuja Jhingran; Travis T Sims; Kathleen Schmeler; Pablo Okhuysen; Lauren E Colbert; Ann H Klopp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-25       Impact factor: 7.038

Review 2.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

Review 3.  Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancer.

Authors:  Nuria Mederos; Alex Friedlaender; Solange Peters; Alfredo Addeo
Journal:  ESMO Open       Date:  2020-11

4.  Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer.

Authors:  Zhe Zhao; Kailun Fei; Hua Bai; Zhijie Wang; Jianchun Duan; Jie Wang
Journal:  Thorac Cancer       Date:  2020-10-27       Impact factor: 3.500

5.  Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.

Authors:  Joseph M Unger; Riha Vaidya; Kathy S Albain; Michael LeBlanc; Lori M Minasian; Carolyn C Gotay; N Lynn Henry; Michael J Fisch; Shing M Lee; Charles D Blanke; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2022-02-04       Impact factor: 50.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.